Trinity St James’s Cancer Institute, Ireland’s first OECI-accredited comprehensive cancer centre, unites research, care and education to advance cancer care.
Joined November 2020
- Tweets 5,874
- Following 478
- Followers 3,585
- Likes 7,520
792 Photos and videos
Pinned Tweet
Having achieved the accreditation as the first Comprehensive Cancer Centre in Ireland we hope we @CancerInstIRE can support national efforts to contribute to a decrease in cancer incidence and mortality in Ireland, and represent as a standard bearer for cancer care.
ALT TSJCI Programme Office with the Minister for Health, R-L Sarah Wade, Project Lead, Nicola Keohane, Young Onset Cancer Coordinator, Dr. Patricia Doherty, TSJCI OECI Coordinator, Cathy Enright, Programme Manager, TSJCI, Minister for Health Jennifer Carroll MacNeill, Sharon Slattery, Director of Nursing, SJH, Prof John Kennedy, Medical Director, TSJCI, Grainne Smith, PPP Lead, TSJCI Prof Lorraine O'Driscoll, TSJCI Research Lead, and Prof Maeve Lowery, Academic Director, TSJCI
5
9
38
4,743
Fantastic opportunity to build essential haematology knowledge. This will be hugely valuable for nurses & AHPs across cancer care. A continued investment in education & training making a real difference to patient care #cancereducation @AudreyOHalloran @CancerInstIRE
🔬Want to build your haematology knowledge? Join our 4 day Fundamentals in Haematology course for Nurses & Allied Health Professionals @stjamesdublin @CancerInstIRE
📅 7th, 14th, 21st & 28th September 2026
👉 Search “Fundamentals in Haematology” on Eventbrite to book.
1
5
301
Trinity St James's Cancer Institute retweeted
Join MSK gastrointestinal medical oncologist Dr. @EileenMOReilly at #ASCO26 for an education session on novel approaches and future directions in targeting KRAS-driven cancers, beyond the G12C mutation. @MSKCancerCenter
🕒 Saturday, May 30 | 1:49 p.m. CDT
Learn more: bit.ly/43BGCPZ
ALT This image is a promotional graphic for a presentation at ASCO 2026. It announces a session titled "Beyond KRAS G12C: Novel Approaches and Future Directions," scheduled for Saturday, May 30, at 1:49 p.m. CDT. It features a photo of Eileen O'Reilly, MD, identified as a gastrointestinal medical oncologist.
3
19
2,162
Trinity St James's Cancer Institute retweeted
Carers Week 2026 - #ThankYouForCaring
This week, we celebrate the incredible family carers who provide unwavering support, comfort, and strength to loved ones living with oesophageal cancer.
Visit ocf.ie for info and resources.
#CarersWeek2026 #OCFbyyourside
5
7
143
An outstanding initiative 👏 Supporting cancer nurses with high-quality education and simulation-based learning is vital to delivering excellent patient care. Well done to all involved @stjamesdublin @CancerInstIRE @TCD_SNM @AudreyOHalloran
📚 Day 5 of our Annual Foundation Course in Cancer Care & Haematology @stjamesdublin @CancerInstIRE. A fantastic programme for cancer nurses, concluded today with a simulation-based assessment @TCD_SNM — an invaluable opportunity to practice in a safe learning environment.
5
248
A landmark moment for pancreatic cancer, these findings highlight what transformative progress can look like. Congratulations to @EileenMOReilly & team @MSKCancerCenter advancing this research driving forward a new standard of care in a disease that has long needed breakthroughs
⚠️ New findings presented in the plenary session at #ASCO26 suggest daraxonrasib could help usher in a new era of treatment for metastatic pancreatic cancer.
In a phase 3 study led by @EileenMOReilly and colleagues, patients receiving #daraxonrasib lived a median of 13.2 months compared with 6.7 months for those treated with chemotherapy.
"To date in my career, I have not seen this level of benefit from any single anti-cancer drug in this disease."
Learn more: bit.ly/435pwKo
1
4
23
2,588
Exciting momentum in precision oncology, congratulations to @MSKCancerCenter @MichaelMayMD on advancing three first‑line metastatic KRAS inhibitor trials opening at @MSKCancerCenter in the coming weeks. A powerful signal of what’s ahead, with many more studies on the horizon.
May 31
Three first line metastatic KRAS inhibitor trials open at @MSKCancerCenter in the next few weeks. Many more here and coming soon in almost every disease setting. @CpcrMsk @EileenMOReilly @CentralParkWMD @AnupriyaSingha9
1
10
1,237
Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) nej.md/4nWaxvM
#ASCO26 | @ASCO
ALT A two-panel line graph shows overall survival in two populations, comparing darovasertib (blue line) and chemotherapy (gray line) treatments. Panel A depicts the RAS G12 population, while Panel B shows the overall population. Hazard ratios and confidence intervals are detailed in each panel.
ALT This image shows two line graphs titled "Progression-free Survival in the RAS G12 Population" and "Progression-free Survival in the Overall Population." Both graphs compare survival rates over 13 months between two groups: one receiving darovasertib and the other receiving chemotherapy. Accompanying the graphs are tables detailing the number of events and patients at risk for each treatment group.
8
348
1,196
69,042
Great to hear this @RTERadio1 feature on cancer innovations @ASCO with @Dr_ClaireK Proud to see the first Public Patient Partnership Lead across @CancerInstIRE & @IrishCancerSoc mentioned, helping embed the patient voice at the heart of clinical care.
rte.ie/radio/radio1/clips/22…
6
149
Incredible progress, redefining what’s possible in even the toughest cancers. The impact of precision oncology in action #ASCO26 @EileenMOReilly @niamhjcoleman @MaeveLowery @MSKCancerCenter @CancerInstIRE
What a moment! Incredible to be in the room for these practice-changing data in such a difficult-to-treat disease 🚀 Another RAS allele is now druggable. The promise of precision oncology—and a powerful reminder of what sustained drug development can achieve. @DavidHongMD #ASCO26
7
273
Truly a landmark moment, incredible leadership from Dr Eileen O’Reilly @EileenMOReilly @MSKCancerCenter @CancerInstIRE driving progress that will change lives. #ASCO26
May 31
4
22
2,326
Fantastic to see such innovative work and research presented on a global stage, congratulations to all involved at @CancerInstIRE @stjamesdublin @TCDdublin @IrishCancerSoc @GrainneSmi63903 #ASCO2026
That’s a wrap on #ASCO2026! An excellent three days with some exciting breakthroughs presented, particularly in hard-to-treat cancers, and lots of learnings on patient advocacy.
We're taking home a real sense of hope for cancer patients globally.
2
9
499
Compelling data, exciting to see this helping shape new thinking around endocrine therapy in precision oncology @niamhjcoleman @mraheelhashim @VivekSubbiah @CancerInstIRE @stjamesdublin @tcddublin #ASCO26
🧬 Hormone receptors: oncology’s original #PrecisionOncology targets🌎 ESR1/AR alterations recur across diverse solid tumors in @AACRFoundationGENIE (>227,000 patients) 🎯 Time to rethink endocrine therapy as a tumor-agnostic strategy? 🎯 #ASCO26 @VivekSubbiah 🙏@mraheelhashim
2
12
248
Fantastic to see this work presented on a global stage, congratulations to all involved at @CancerInstIRE @stjamesdublin @TCDdublin @mraheelhashim @niamhjcoleman @VivekSubbiah #ASCO2026
May 30
Excited to present our work with @niamhjcoleman @VivekSubbiah
Thanks to @ASCO @AACR for this opportunity
@CancerInstIRE @stjamesdublin
1
7
208
Fantastic to see Gráinne @CancerInstIRE @stjamesdublin @tcddublin PPP Lead proudly representing our partnership with the @IrishCancerSoc at #ASCO2026!
Our Head of Research, Dr Claire Kilty, is thrilled to touch down in Chicago for #ASCO2026 to represent the Irish Cancer Society and our partnership with Grainne Smith @stjamesdublin at the world's largest cancer conference.
9
284
Irish oncologist helps lead breakthrough pancreatic cancer pill. Major leap forward, incredible to see @CancerInstIRE External Advisory Board Chair Dr Eileen O’Reilly @EileenMOReilly & team @MSKCancerCenter leading the way in this game-changing step. bit.ly/4uaecaU
May 31
Congratulations @EileenMOReilly @MSKCancerCenter @MSK_DeptOfMed Brian Wolpin Ziv Wainberg and all colleagues on a long awaited and badly needed game changer in #pancreascancer
16
440
Incredible moment. Congratulations to all involved. A powerful step forward for pancreatic cancer patients globally. #PancreaticCancer #CancerResearch @DrSamuelBHume @CancerInstIRE @stjamesdublin @tcddublin @TrinityMed1
May 31
One of the most amazing things I’ve ever seen: a standing ovation for the full Daraxonrasib results
I feel inspired and energised, to put it mildly — we have a targeted therapy for pancreatic cancer now, and nothing is undruggable anymore
1
9
270
Proud to see @IrishCancerSoc and so many Irish cancer experts making an impact at #ASCO! 👏 Inspiring research, global collaboration, and real progress for patients 🇮🇪✨ #CancerResearch @CancerInstIRE @stjamesdublin
First ASCO filled with lots of learning, inspiring research and great Irish representation 🇮🇪 🔬 💫
4
8
314
@ASCO2026 Dr Ng, Dr Bergerot, Dr Su on the need for specialised services for young onset cancers - fertility, sexual health, psychosocial, financial, survivorship. The Young Onset Cancer Progamme in TSJCI @stjamesdublin in partnership with @IrishCancerSoc offers these services
2
6
136
Day 2 #ASCO2026 - surviving cancer isn’t the only thing that matters, how patients feel during treatment matters just as much. Using Patient Reported Outcomes to measure what actually matters to patients needs to be built into research and care. @stjamesdublin @IrishCancerSoc
8
130
Fascinating talk by Dr Eric Small, President of ASCO, on the importance of prioritising quality of life and patients' needs first. This became more apparent to him through personal experience. @stjamesdublin @IrishCancerSoc #PatientFirst #PatientPartnership
1
8
186